Gene Query: HRAS

Dataset Description Geneva Score
MCF10A H-Ras RNA-Seq 85.83
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 45.58
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 35.48
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 29.7
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 25.32
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 22.71
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 20.99
Selective expression of long non-coding RNAs in a breast cancer cell progression model 19.83
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 19.27
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 19.17
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 17.55
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 16.46
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 16.05
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 16.0
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 16.0
SLAM-seq for K562 endogenous mRNA decay 15.1
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 14.59
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 12.76
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 12.75
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 12.73
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 12.55
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 12.48
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 12.01
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 11.96
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 11.67
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 11.54
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 11.46
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 11.43
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 10.94
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 10.84
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 10.78
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 10.62
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 10.57
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 10.02
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 9.95
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 9.95
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 9.84
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 9.82
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 9.82
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 9.69
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 9.69
RNAseq Study in CC-671 Treated Cal-51 Cells 9.67
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 9.37
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 9.32
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 8.92
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 8.92
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 8.66
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 8.56
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 8.51
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 8.43
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 8.4
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 8.4
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 8.34
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 8.19
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 8.19
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 8.17
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 7.96
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 7.88
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 7.68
DART-seq: an antibody-free method for global m6A detection 7.67
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 7.67
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 7.58
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 7.5
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 7.46
Genome-wide transcriptional response to random aneuploidy in human cells 7.42
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 7.39
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 7.12
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 7.11
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 7.03
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 7.0
ETV7 and interferon response 7.0
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 6.96
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 6.96
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 6.96
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 6.9
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 6.89
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 6.8
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 6.78
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 6.64
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 6.58
Effect of mitochondria deficiency on senescence-associated gene expression 6.55
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 6.51
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 6.51
Aneuploidy-induced cellular stresses limit autophagic degradation. 6.49
Regulation of highly expressed hCINAP on translatome 6.46
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 6.41
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 6.37
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 6.37
The effect of PPARG inhibition on human angiomyolipoma cells 6.33
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 6.33
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 6.29
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 6.29
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 6.28
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 6.28
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 6.25
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 6.24
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 6.24
Identification of HOXB13 target genes responsive to BET inhibitors 6.21
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 6.2
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 6.08
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 6.07
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 6.06
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 6.05
BAF controls genome accessibility 6.05
RNA Seq of HMVEC under hypoxia 6.02
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 6.02
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 5.95
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 5.95
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 5.94
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 5.94
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 5.88
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 5.88
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 5.83
CHD1 regulates cell fate determination by activation of differentiation-induced genes 5.62
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 5.62
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 5.6
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 5.59
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 5.53
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 5.49
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 5.49
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 5.49
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 5.46
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 5.41
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 5.37
Survival of pancreatic cancer cells lacking KRAS function 5.33
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 5.28
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 5.23
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 5.19
Glioblastoma stem cells infected by ZIKA virus 5.16
RNA-seq analysis upon ARID1B overexpression 5.11
SNHG5 siRNA knock down in HCT116 cells 5.08
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 5.08
CHCHD10 gene KO effect in iPSC drived motor neurons 5.08
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 5.04
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 5.02
Impact of dieldrin on transcription in Jurkat T cells 5.02
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 5.0
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 4.93
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 4.91
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 4.87
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 4.81
Neonatal and adult human testis defined at the single-cell level 4.79
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 4.78
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 4.78
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 4.76
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 4.72
MYCi975 regulates MYC target genes 4.7
Analysis of transcriptional regulation by Myt1 and Myt1l 4.7
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 4.67
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 4.59
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 4.58
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 4.58
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 4.58
RNA-seq of shEZH2 cells 4.56
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 4.54
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.5
RNA-seq analysis of uveal melanoma cells treated with FR900359 4.41
RNAseq of cell lines with knocked in ESR1 mutations 4.4
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 4.4
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 4.38
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 4.38
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 4.34
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 4.34
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 4.32
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 4.31
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 4.26
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 4.22
Expression level comparison under dividing and quiescent states in human primary fibroblasts 4.21
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 4.19
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 4.18
Silencing p300 in MCF7 cells to study expression and alternative splicing 4.17
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 4.17
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 4.17
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 4.17
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 4.13
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 4.11
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 4.1
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 4.1
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 4.1
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 4.1
Identification of Sin3B regulated genes during quiescence 4.09
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 4.09
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 4.09
Gene expression changes caused by KRAS in MCF-10A 4.03
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 4.0
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 4.0
ENCODE Cold Spring Harbor Labs Long RNA-seq 3.99
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.97
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 3.96
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 3.95
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 3.94
Copper Regulation of HIF-1 Transcription Activity 3.94
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.92
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.92
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 3.91
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 3.84
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 3.84
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 3.83
Regulatory network controlling tumor-promoting inflammation in human cancers 3.83
A single cell reference map for human blood and tissue T cell activation 3.83
Generating Patterned Kidney Organoids for Studying Development and Diseases 3.82
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 3.81
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 3.81
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 3.8
Splicing and epigenetic factors jointly regulate epidermal differentiation 3.77
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 3.75
The comparison of high-throughput single-cell RNA-seq methods 3.75
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 3.75
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 3.74
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 3.73
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 3.73
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 3.73
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 3.72
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 3.72
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 3.72
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 3.71
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.71
PRDM1 inhibits proliferation of human colon cancer organoids 3.7
The transcriptome effect of overexpressing EZH2 in MCF7 3.68
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 3.68
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 3.67
Endothelial gene expression analysis 3.67
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 3.67
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 3.67
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 3.65
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 3.63
Regulating Interleukin-2 activity with engineered receptor signaling clamps 3.59
High-Throughput Kinetic Analysis of Fractional Killing 3.57
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 3.56
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 3.43
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 3.42
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 3.39
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 3.36
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 3.36
Identification of long noncoding RNAs regulated by p53 3.35
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 3.35
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 3.33
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 3.32
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 3.31
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 3.28
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 3.25
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 3.24
RNA-seq analysis of control and Myc-induced U2OS cells 3.23
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 3.2
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 3.17
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 3.15
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 3.14
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 3.12
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 3.01
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 3.0
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 2.96
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 2.94
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.91
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 2.89
RNA-seq of human aneuploid cell lines with Trisomy 21 2.88
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 2.87
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 2.87
Triple vectors expand AAV transfer capacity in the retina 2.87
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 2.86
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 2.85
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 2.82
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 2.82
RNA editing in nascent RNA affects pre-mRNA splicing 2.81
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 2.81
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 2.81
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 2.81
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 2.79
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 2.78
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 2.77
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 2.77
Controlling for gene expression changes in transcription factor protein networks. 2.76
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 2.75
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 2.73
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 2.73
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 2.73
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.73
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 2.72
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 2.7
CHCHD2 gene KO effect in iPSC drived motor neurons 2.69
KLF6-dependent transcription in renal cancer cells 2.65
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 2.65
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 2.65
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 2.64
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 2.61
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 2.6
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 2.6
miRNAs affected by antagomiR-17 treatment 2.59
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.59
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 2.57
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 2.56
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 2.56
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 2.56
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 2.55
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 2.54
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 2.51
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 2.49
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 2.49
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 2.47
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 2.46
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 2.42
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 2.38
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 2.38
SETBP1-WT and SETBP1-G870S epigenetic landscapes 2.34
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 2.34
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 2.3
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 2.29
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 2.28
Gene expression analysis upon mtDNA depletion 2.28
Gene expression analysis upon mtDNA depletion [RNA-seq] 2.28
Ribosome profiling upon inhibition of eIF4A 2.24
RNA-Seq of PRMT1 overexpression ECA109 cells 2.22
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 2.22
Human Treg NaCl stimulation 2.19
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 2.17
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 2.16
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  2.16
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.15
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 2.14
Cajal bodies are linked to genome conformation 2.14
Cajal bodies are linked to genome conformation [RNA-Seq] 2.14
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 2.13
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 2.12
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 2.12
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.1
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 2.07
Positively selected enhancer elements endow tumor cells with metastatic competence 2.07
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.06
Transcriptome sequencing of K-562 cells 2.04
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 2.04
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 2.04
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 2.04
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 2.04
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 2.04
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 2.02
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 2.02
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 2.02
Real-time observation of light-controlled transcription in living cells 2.01
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 1.99
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 1.98
RNA splicing alteration on glioblastoma and normal neural stem cells 1.96
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 1.94
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 1.92
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 1.92
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 1.9
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 1.89
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 1.86
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 1.84
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 1.81
Efficient derivation of microglia-like cells from human pluripotent stem cells 1.75
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 1.74
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 1.71
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.69
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 1.68
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.67
AUF-1 affected genes in human skin cells 1.66
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 1.65
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.64
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 1.63
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.63
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.63
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.62
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.59
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 1.59
The role of the Calcium-Sensing receptor in colorectal cancer 1.55
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 1.55
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 1.55
The circadian transcriptional landscape in primary human mammary epithelial cells 1.51
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.49
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 1.45
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 1.44
Co-regulation of splicing by Rbfox1 and hnRNP M 1.42
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 1.42
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 1.41
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 1.41
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.4
Genetic-to-epigenetic Therapy for Pancreatic Cancer 1.4
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.39
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 1.39
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 1.38
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 1.36
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 1.34
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 1.33
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.33
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.31
Functional significance of the HIV-1 Tat signature amino acid residues 1.3
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 1.29
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 1.28
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 1.27
HBEC-shp53-PCHD7 1.22
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 1.21
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.2
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.18
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 1.14
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 1.14
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.1
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 1.09
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 1.08
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 1.06
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 1.05
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 1.05
SRSF1 role in cellular gene expression and splicing 1.05
Single cell transcriptome of peritoneal cells 1.05
Gene expression profile in breast cancer cells 1.04
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.04
Solid phase chemistry to covalently and reversibly capture thiolated RNA 1.04
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 1.04
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.04
Effects of transcription on genome - nuclear lamina interactions 0.99
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.99
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 0.99
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.95
MCF-7 as a model for functional analysis of breast cancer risk variants 0.95
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 0.93
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 0.92
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 0.91
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.9
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.89
The MEF2B Regulatory Network - RNA-seq data 0.87
The MEF2B Regulatory Network 0.87
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.85
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 0.82
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.82
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 0.81
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 0.8
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.78
Effect of from Human Umbilical Vein Endothelial Cells 0.78
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 0.78
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 0.75
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 0.7
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.7
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.68
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.68
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 0.68
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 0.68
EGR1-controlled transcriptome of T HESCs 0.68
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 0.68
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.65
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 0.65
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 0.65
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.64
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.64
H1609088 Human RNA-Sequencing 0.62
Downregulation of LATS kinases alters p53 to promote cell migration 0.61
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.6
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.6
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 0.59
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 0.58
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.58
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.58
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 0.57
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 0.57
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 0.54
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 0.53
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.53
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 0.52
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.52
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.48
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.47
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.47
Ribosomal protein RPL26 is the principal target of UFMylation 0.44
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 0.43
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 0.43
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 0.43
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.42
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.38
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.37
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.36
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.32
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.32
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.3
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.29
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.27
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.27
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.27
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 0.26
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.26
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.24
RNA-seq of MDA-MB-231 cells with TET1 knockout 0.24
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.23
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.23
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.23
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.2
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.2
FBXW7 modulates stress response by post-translational modification of HSF1 0.19
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 0.19
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.18
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.16
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.14
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 0.13
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.1
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.1
Mutational landscape of splicing genes and functional consequences across 33 cancer types 0.09
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.08
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 0.06
CUREfast: Accelerating research with families 0.06
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.05
6mer seed toxicity in tumour suppressive microRNAs 0.03
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.02
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.02
Metabolism as an early predictor of DPSCs aging 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation